Abstract
Given the impact of the coronavirus disease 2019 (COVID-19) on patients with psoriatic disease (PsD), a session was devoted at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 annual meeting to discussing the current understanding of the risk of severe COVID-19 in patients with PsD. The effects of PsD and its treatment on prevention and treatment of COVID-19 with vaccinations, antiviral drugs, and monoclonal antibodies were discussed. The session concluded with a presentation on the perspectives of patient research partners about their experiences with COVID-19.
| Original language | English |
|---|---|
| Pages (from-to) | 27-30 |
| Number of pages | 4 |
| Journal | Journal of Rheumatology |
| Volume | 50 |
| DOIs | |
| State | Published - Nov 1 2023 |
| Externally published | Yes |
Keywords
- COVID-19
- GRAPPA
- psoriasis
- psoriatic
- vaccines
Fingerprint
Dive into the research topics of 'Impact of COVID-19 on Patients With Psoriasis or Psoriatic Arthritis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver